Clinical Trials Browser

Phase 1 × nintedanib × Genitourinary × Clear all

NCT02182219 2025-01-22

Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT02835833 2018-07-10

Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors

Phase 1 Completed

GenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms